Skip to content

Vancomycin 30 (B) E112023

by BioMaxima Spółka Akcyjna Poland EUDAMED

Ref E112023 (W)

EMDN W0104080502

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR Number59026439BASTVAMH Basic UDI-DIDate11 Jul 2025RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Not covered

European Union — CE/IVDR Active

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 22 Oct 2026

Device Name
Vancomycin 30 (B) E112023
Model / Reference
E112023 (W)
Primary DI / UDI-DI
05902643982253
Basic UDI-DI
59026439BASTVAMH
EMDN Code
W0104080502 Impregnated disks, multi-disks & tablets
Device Class
Class B
Market of Registration
Poland

Manufacturer details

EUDAMED SRN
PL-MF-000039473

Other devices from BioMaxima Spółka Akcyjna

See all devices from BioMaxima Spółka Akcyjna →

Properties & raw data

Show properties, registry sources and raw records
  • Professional Testing
Other properties (10)
  • Sterile: No
  • Human Tissues: No
  • Animal Tissues: No
  • Microbial Substances: No
  • Reagent: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No
  • New Device: No

Sources (1)

  • EUDAMED be5491d7-24c5-48b5-a673-d886a84f750b 61 fields · synced 22 Oct 2026